COST ANALYSIS STUDY OF ORAL ANTIDIABETIC DRUGS AVAILABLE IN INDIAN MARKET

Abstract

Introduction: There exists a wide range of variation in the prices of drugs marketed in India and other countries of the world. Very few studies have been conducted to reveal such price variations in the open market. Aim & Objectives: To evaluate the cost of oral anti-diabetics of different generic classes and different brand names of one compound, To evaluate the difference in cost of different brands for the same active drug by calculating percentage variation of cost. Methods: Cost of a particular drug being manufactured by different companies, in the same strength, number and dosage form was compared. The difference in the maximum and minimum price of the same drug manufactured by different pharmaceutical companies and the percentage variation in price was calculated. Results: In Single drug therapy, among sulfonylurea group of drugs, Glimepiride (1 mg) shows maximum price variation of 655.38%, while Glipizide (10mg) shows variation of 38.88%. In Biguanides & Thizolidinediones groups of drugs, Metformin (500 mg) & Pioglitazone (15 mg) show maximum price variation of 308.33% & 542% respectively. In α-glucosidases inhibitor group of drugs, Miglitol shows maximum price variation of 135.50 %. In combination therapies, Glipizide & Metformin combination shows the maximum variation up to 399.04 %. Conclusion: The average percentage price variation of different brands of the same drug manufactured in India is very wide and the appraisal and management of marketing drugs should be directed toward maximizing the benefits of therapy and minimizing negative personal and economic consequences.

Authors and Affiliations

Nisharani B Jadhav| Department of pharmacology, B. L. D. E. U.’s S B M Patil Medical College, Bijapur, Karnataka, India corresponding author email: drnishajadhav@gmail.com, Manisha S Bhosale| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008, Charles V Adhav| Department of Pharmacology, Topiwala National Medical College and B. Y. L. Nair Charitable Hospital, Mumbai-Central, Mumbai, Maharashtra, India. 400008

Keywords

Related Articles

Comparison Nokia, Samsung and Sony mobile phones in the specific absorption rate of head induced to electric field

The use of mobile phones has expanded in recent decades. Despite the extensive studies in this field, less attention has been paid to the biological effects of electromagnetic fields emitted by the mobile phones. Theref...

DEGREE AND ONSET OF MYDRIASIS CAUSED BY MYDRIATIC AGENTS WITH SPECIAL REFERENCE TO TOBACCO ADDICTION

Introduction: The quality of an intra-ocular examination depends on adequate pupil dilation (mydriasis). Magnitude of dilation depends on sphincter and dilator muscles of pupil. Most frequently used drugs in ophthalmol...

CONTINUING PROFESSIONAL DEVELOPMENT IN RADIOGRAPHY: PRACTICE, ATTITUDE AND BARRIERS

Aim: The study aimed to examine attitudes and practice of radiographer in the fields of CPD and ascertain barriers of CPD in Sudan. Method & Material: A questionnaire to collect quantitative data and all participants...

Effectiveness of Botox in Treating Chronic Anal Fissure: A Clinical Experience with Mid-Term Follow Up

Chronic anal fssure (CAF) is a common distressing problem with high recurrence rates. For many years, lateral internal sphincterotomy was the main treatment for CAF. Recently, intrasphincteric injection of botulinum tox...

Co-occurrence of Gardnerellavaginalis and Candida sp. in women with and without vulvovaginitis

Aims: To detect the co-occurrence of Gardnerellavaginalis and Candida sp.in women with and without vaginal symptoms. Methods: A cross-sectional study was performed in women seeking treatment in a Brazilian city from Ma...

Download PDF file
  • EP ID EP10952
  • DOI -
  • Views 385
  • Downloads 22

How To Cite

Nisharani B Jadhav, Manisha S Bhosale, Charles V Adhav (2013). COST ANALYSIS STUDY OF ORAL ANTIDIABETIC DRUGS AVAILABLE IN INDIAN MARKET. International Journal of Medical Research & Health Sciences (IJMRHS), 2(1), 63-69. https://europub.co.uk/articles/-A-10952